Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: A behavioral analysis

被引:54
作者
Baluchnejadmojarad, Tourandokht
Roghani, Mehrdad
机构
[1] Iran Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran
[2] Shahed Univ, Sch Med, Dept Physiol, Tehran, Iran
[3] Shahed Univ, Sch Med, Med Plant Res Ctr, Tehran, Iran
关键词
naringenin; streptozotocin; learning; memory; spatial cognition;
D O I
10.1159/000096585
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Intracerebroventricular (ICV) injection of streptozotocin (STZ) causes cognitive impairment in rats. The beneficial effect of naringenin (NAR) was investigated on ICV STZ-induced learning, memory, and cognitive impairment in male rats. For this purpose, rats were injected with ICV STZ bilaterally, on days 1 and 3 (3 mg/kg). The STZ-injected rats received NAR (50 mg/kg/day p.o.) starting 1 day pre-surgery for 3 weeks. The learning and memory performance was assessed using passive avoidance paradigm, and for spatial cognition evaluation, radial eight-arm maze (RAM) task was used. It was found out that NAR-treated STZ-injected rats show higher correct choices and lower errors in RAM than vehicle-treated STZ-injected rats. In addition, NAR administration significantly attenuated learning and memory impairment in treated STZ-injected group in passive avoidance test. Therefore, these results demonstrate the effectiveness of NAR in preventing the cognitive deficits caused by ICV STZ in rats and its potential in the treatment of neurodegenerative diseases such as Alzheimer's disease. Copyright (c) 2006 S. Karger AG, Basel
引用
收藏
页码:193 / 197
页数:5
相关论文
共 20 条
[1]
CARR DB, 1997, AM J MED, V103, P3
[2]
Chu Wen-Zheng, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P168
[3]
Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E [J].
Fukui, K ;
Omoi, NO ;
Hayasaka, T ;
Shinnkai, T ;
Suzuki, S ;
Abe, K ;
Urano, S .
INCREASING HEALTHY LIFE SPAN: CONVENTIONAL MEASURES AND SLOWING THE INNATE AGING PROCESS, 2002, 959 :275-284
[4]
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease [J].
Gasparini, L ;
Racchi, M ;
Binetti, G ;
Trabucchi, M ;
Solerte, SB ;
Alkon, D ;
Etcheberrigaray, R ;
Gibson, G ;
Blass, J ;
Paoletti, R ;
Govoni, S .
FASEB JOURNAL, 1998, 12 (01) :17-34
[5]
Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease [J].
Grünblatt, E ;
Hoyer, S ;
Riederer, P .
JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (03) :367-386
[6]
Effect of antioxidant flavanone, naringenin, from Citrus junos on neuroprotection [J].
Heo, HJ ;
Kim, DO ;
Shin, SC ;
Kim, MJ ;
Kim, BG ;
Shin, DH .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2004, 52 (06) :1520-1525
[7]
Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia [J].
Heo, HJ ;
Kim, MJ ;
Lee, JM ;
Choi, SJ ;
Cho, HY ;
Hong, BS ;
Kim, HK ;
Kim, E ;
Shin, DH .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (03) :151-157
[8]
Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic ceramide analog (L-PDMP) [J].
Inokuchi, J ;
Mizutani, A ;
Jimbo, M ;
Usuki, S ;
Yamagishi, K ;
Mochizuki, H ;
Muramoto, K ;
Kobayashi, K ;
Kuroda, Y ;
Iwasaki, K ;
Ohgami, Y ;
Fujiwara, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) :595-600
[9]
Jiang Fan, 2003, Current Vascular Pharmacology, V1, P135, DOI 10.2174/1570161033476736
[10]
Kumar MHV, 2003, CLIN EXP PHARMACOL P, V30, P336, DOI 10.1046/j.1440-1681.2003.03842.x